Healthsouth Corp (HLS) 45.30 $HLS The Most Valuable

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Healthsouth Corp (HLS) 45.30 $HLS

The Most Valuable Updates in the Healthcare Sector: Special Research on HealthSouth, Capital Senior Living, Davita, Envision, and Five Star Quality Care
PR Newswire - Mon Mar 16, 6:40AM CDT
Editor Note: For more information about this release, please scroll to bottom.
FVE: 4.22 (+0.11), CSU: 25.92 (-0.43), DVA: 81.86 (+0.42), EVHC: 38.60 (+0.42), HLS: 45.30 (+0.35)

HealthSouth Announces Pricing Of $300 Million Senior Notes Offering
PR Newswire - Mon Mar 09, 4:02PM CDT
HealthSouth Corporation (NYSE: HLS) today announced the pricing of its underwritten public offering of $300 million of its 5.125% senior notes due 2023 at a public offering price of 100.000% of the principal amount. The Company will pay interest on the notes semiannually in arrears on March 15 and September 15 of each year, beginning on September 15, 2015. The notes will be jointly and severally guaranteed on a senior unsecured basis by all of its existing and future subsidiaries that guarantee borrowings under the Company's credit agreement and other capital markets debt. The offering is expected to close on March 12, 2015 and is conditioned on the satisfaction of customary closing conditions.
HLS: 45.30 (+0.35)

HealthSouth Announces Launch Of $300 Million Senior Notes Offering Due 2023 And Intent To Redeem $290 Million Of Senior Notes Due 2020
PR Newswire - Mon Mar 09, 8:23AM CDT
HealthSouth Corporation (NYSE: HLS) today announced it has commenced a public offering of $300 million of senior notes due 2023. The Company intends to give notice of its intent to redeem all the outstanding $290 million of its 8.125% senior notes due 2020. The Company intends to use the net proceeds from this offering along with cash on hand to fund the redemption.
HLS: 45.30 (+0.35)

International Essential Tremor Foundation to Facilitate Educational Seminar in Williamsport, PA
PRWeb - Mon Mar 02, 10:00AM CST
The International Essential Tremor Foundation (IETF) will host a free seminar in Williamsport, Penn. on the life-altering neurological condition called essential tremor (ET). The seminar will take place on Saturday, March 14 at the Holiday Inn Downtown Williamsport located at 100 Pine St. The program will run from 9:30 a.m. to 12 p.m., with a question and answer session with the physicians directly following the presentation. More information, including driving directions and event registration, is available by phone (toll free) at 888.387.3667 or on the web at http://www.essentialtremor.org/seminars.
HLS: 45.30 (+0.35)

Amsurg (AMSG) Beats Q4 Earnings, Revenues; Outlook Bright - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 26, 8:58AM CST
Amsurg Corp. (AMSG) reported a solid fourth-quarter 2014 with adjusted earnings per share (EPS) of 72 cents.
AMSG: 64.02 (-0.19), DGX: 76.74 (+0.56), AMED: 26.74 (-0.25), HLS: 45.30 (+0.35)

HealthSouth (HLS) Jay F. Grinney on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Feb 25, 2:45PM CST

HLS: 45.30 (+0.35)

HealthSouth misses by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 24, 3:39PM CST

HLS: 45.30 (+0.35)

Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 23, 4:35PM CST

AMRS: 2.34 (-0.16), AWAY: 31.29 (+0.33), HWAY: 21.46 (-0.09), FLTX: 44.22 (+0.70), HLS: 45.30 (+0.35), RRC: 49.35 (+1.70), DY: 46.96 (-0.13), MATX: 41.66 (+0.06), NYMT: 8.11 (+0.10), NSTG: 11.48 (-0.05), PZZA: 64.30 (+0.63), SGY: 14.10 (-0.01), HEP: 31.08 (-0.32), ARC: 8.80 (-0.09), BGFV: 13.54 (+0.44), RJET: 14.67 (+0.07), RLYP: 40.04 (unch), SAM: 277.36 (+9.46), DWA: 22.00 (+0.12), NKTR: 12.02 (+0.13), FSLR: 60.26 (-0.04), NFX: 33.29 (+0.82), KONA: 26.80 (+0.20), BBRG: 14.71 (+0.16), HEI: 59.84 (unch), CLR: 41.07 (+0.69), ACAS: 14.94 (+0.13), RUBI: 18.18 (-0.21), HURN: 66.50 (-0.88), GB: 56.06 (+0.57), BNFT: 39.22 (+0.92), AWK: 55.02 (+0.68), NUVA: 45.60 (-1.07), BOOM: 14.01 (unch), CENX: 14.04 (-0.11), GNMK: 13.82 (+0.36), QEP: 20.78 (+0.38), FMI: 48.11 (-0.29), KRA: 19.70 (+0.81), DPM: 38.79 (+1.03), JAZZ: 189.01 (+1.89), INFI: 15.39 (-1.14), EPR: 61.78 (+1.47), EXEL: 2.82 (-0.02), CBI: 45.29 (+0.86), NDSN: 78.26 (+0.13), ORA: 37.93 (+0.08), CPRT: 37.80 (+0.43), SM: 47.09 (+1.88), HPQ: 33.28 (+0.44), NLY: 10.74 (+0.04), LC: 20.09 (+0.17), DYN: 28.08 (+0.18), CLGX: 34.40 (+0.51), SLCA: 31.49 (+1.66), EIX: 64.17 (-0.64), MMSI: 19.40 (-0.02)

Seeking Daruma: Zen And The Art Of Small Cap Investing
Matthew Finston - at Seeking Alpha - Fri Feb 20, 10:07AM CST

CSGP: 196.78 (-0.88), PRGO: 172.87 (+2.50), XYL: 35.99 (+0.45), FRAN: 16.13 (+0.08), TTI: 5.91 (+0.27), LL: 28.51 (-0.84), HLS: 45.30 (+0.35), GOOG: 560.36 (+2.37), PVH: 102.44 (+0.81), STNG: 9.05 (+0.04), ROG: 83.28 (+0.29), TRAK: 38.84 (-0.25), WCG: 93.72 (+0.61), MD: 72.46 (+0.32), SPN: 21.19 (+0.82), MU: 28.68 (+0.63), WLL: 39.03 (-1.04), EFII: 42.06 (+0.77), DGI: 34.75 (+0.04), PBI: 23.96 (+0.71), UHS: 118.76 (+0.03), CDNS: 18.66 (+0.06), BECN: 30.43 (+1.08), NXPI: 108.03 (+2.71), LYV: 25.50 (-0.01), PODD: 33.95 (-0.43), WEX: 107.22 (+3.31), ASGN: 38.80 (+0.13), AIG: 55.94 (+0.29), CTCT: 38.97 (+0.69), OXM: 58.38 (-0.08), STKL: 11.01 (+0.50), AWI: 57.53 (+1.24), MFRM: 67.72 (+3.69), BDC: 92.13 (+1.46), QEP: 20.78 (+0.38), BC: 51.25 (+0.15), SHLM: 44.79 (+0.45), MNRO: 66.92 (+0.74), VRA: 15.84 (-0.01), GOOGL: 564.95 (+1.28), AVY: 53.49 (+0.49), OC: 42.43 (+2.71), WAB: 96.57 (+1.39), CRZO: 47.86 (+1.37), NATI: 32.83 (-0.02), DBD: 34.59 (+0.39), RATE: 11.73 (+0.13), ALGN: 57.18 (-1.14), FBHS: 46.16 (+1.08), WDC: 100.44 (+1.14), DIN: 106.25 (+0.23), ACXM: 19.59 (unch), TCBI: 49.54 (+0.91), PLL: 103.61 (-0.47), FUL: 43.81 (+0.49), PCRX: 97.64 (-0.08), BABA: 85.20 (-0.54)

Next Week In Biotech: Arena And Vivus Report, Radiesse And Avedro Ad Comms
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 8:00AM CST
Every Friday morning, Seeking Alpha posts a calendar of the next week's expected biotech events to start a forward-looking conversation. Please be aware that dates and events can be subject to change. Please let us know in a comment or message if you...
LXRX: 1.10 (-0.04), AMRN: 2.52 (-0.03), HWAY: 21.46 (-0.09), HLS: 45.30 (+0.35), CYBX: 65.21 (-0.46), ESRX: 85.38 (+1.43), ECYT: 5.96 (-0.06), DXCM: 61.97 (-1.47), NSTG: 11.48 (-0.05), SRPT: 13.16 (-0.76), HZNP: 22.77 (-0.30), MDXG: 9.89 (-0.30), DEPO: 24.12 (-0.75), ANIK: 40.84 (-0.63), NKTR: 12.02 (+0.13), KERX: 14.31 (+0.68), ALIM: 5.12 (+0.08), EPZM: 19.91 (-0.88), AEGR: 27.20 (-0.20), MDRX: 12.05 (-0.06), ELGX: 16.49 (+0.07), NUVA: 45.60 (-1.07), HPTX: 40.49 (+0.85), GNMK: 13.82 (+0.36), MDVN: 135.56 (+1.09), HBIO: 5.40 (+0.13), ACAD: 34.45 (-0.54), ST: 57.45 (+0.54), RPTP: 11.86 (+0.14), FMI: 48.11 (-0.29), GMED: 24.61 (-0.53), JAZZ: 189.01 (+1.89), PTCT: 70.05 (+0.82), INFI: 15.39 (-1.14), ARNA: 4.80 (-0.21), EXEL: 2.82 (-0.02), NEO: 4.96 (+0.02), EXAS: 24.18 (-0.20), ALKS: 67.20 (-0.86), HTWR: 85.97 (-0.51), MNKD: 5.26 (-0.28), IPXL: 46.34 (-0.47), SQNM: 3.91 (-0.03), HALO: 14.63 (-1.43), ISIS: 73.59 (-3.49), CLVS: 78.26 (-3.17), BIO: 134.98 (-1.35), BIOS: 4.49 (-0.06), PCRX: 97.64 (-0.08)

HealthSouth declares $0.21 dividend
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 3:46PM CST

HLS: 45.30 (+0.35)

HealthSouth To Present At The Raymond James 36th Annual Institutional Investors Conference
PR Newswire - Wed Feb 18, 11:24AM CST
HealthSouth Corporation (NYSE: HLS) today announced it will participate in the Raymond James 36th Annual Institutional Investors Conference in Orlando, FL on March 2-3, 2015.
HLS: 45.30 (+0.35)

Will DENTSPLY International (XRAY) Miss Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 16, 11:00AM CST
Our proven model does not conclusively show that DENTSPLY International Inc. (XRAY) is likely to beat earnings this quarter.
BLUE: 124.76 (-1.64), ACT: 317.06 (+2.65), HLS: 45.30 (+0.35), XRAY: 51.80 (-0.14)

Will Masimo Corp (MASI) Disappoint Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:30AM CST
Our proven model does not conclusively show that Masimo Corp (MASI) is likely to beat earnings this quarter.
BLUE: 124.76 (-1.64), ACT: 317.06 (+2.65), MASI: 31.01 (-0.55), HLS: 45.30 (+0.35)

2015 New-Year Coverage Universe Updates
DAG Investments - at Seeking Alpha - Thu Feb 12, 9:10AM CST

ACET: 21.89 (-0.28), GE: 25.40 (+0.07), KR: 76.83 (+0.43), BX: 38.69 (unch), CCLP: 17.38 (+0.36), CECE: 12.06 (-0.05), PFE: 34.25 (+0.10), HAL: 42.82 (+1.27), SPWR: 32.87 (-0.22), HLS: 45.30 (+0.35), MTW: 21.67 (+0.21), AET: 108.63 (+0.32), MWA: 9.77 (+0.10), VLO: 61.55 (+0.75), FSLR: 60.26 (-0.04), WBA: 88.23 (+0.87), RJF: 58.23 (+0.81), TRN: 35.28 (+1.28), CWCO: 9.81 (-0.20), WMB: 48.28 (+0.35), ANAC: 54.24 (-1.88), SXI: 83.20 (+3.51), IHG: 40.48 (+0.42)

A Choppy Start to a New Year - Analyst Blog
John Blank - Zacks Investment Research - Mon Feb 09, 12:50PM CST
Cuts to Energy EPS had made for a choppy start to the New Year for the S&P 500.
CVS: 103.86 (+0.52), TSM: 24.77 (+0.11), HLS: 45.30 (+0.35)

Will Thoratec (THOR) Miss Earnings Estimates in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 3:42PM CST
Our proven model does not conclusively show that Thoratec Corp. (THOR) is likely to beat earnings this quarter.
ACT: 317.06 (+2.65), THOR: 40.14 (-0.40), INFI: 15.39 (-1.14), HLS: 45.30 (+0.35)

Anthem Shares Fall Post Huge Data Breach, China Suspected - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 1:27PM CST
After a series of data breaches at major U.S. companies over the past two years it is now health insurer Anthem Inc. (ANTM) which has been struck.
ANTM: 158.38 (+1.06), UNH: 119.14 (-1.62), AMED: 26.74 (-0.25), HLS: 45.30 (+0.35)

Quest Diagnostics Strong on Earnings, Long-Term Prospects - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 06, 10:32AM CST
On Feb 5, 2015, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
USPH: 48.49 (+0.11), DGX: 76.74 (+0.56), AMED: 26.74 (-0.25), HLS: 45.30 (+0.35)

Will Sirona Dental Systems (SIRO) Miss Earnings in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 04, 9:40AM CST
Our proven model does not conclusively show that Sirona Dental Systems Inc. (SIRO) is likely to beat earnings this quarter.
SIRO: 88.85 (-0.26), PDCO: 50.34 (+0.52), HLS: 45.30 (+0.35), HSIC: 143.01 (+2.32)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lawyers Juggle AI's Promise and Perils in 2026

Updated Category News Views 104

AI's Growing Pains in the Legal Arena Looks like the legal eagles are getting a run for their money with AI entering the courtroom. Bloomberg Law's 2026 AI in Practice report dives deep into this legal labyrinth. You got attorneys leaning on AI to keep the gears turning, but they're also clutching their pearls over potential pitfalls. Trust Issues: Humans vs. Machines The...

Continue Reading
Siemens Set to Acquire Lauterbach in Strategic Move

Updated Category News Views 81

Siemens Seizing New Opportunities with Lauterbach Acquisition Bam! Siemens is on the move, folks, snapping up Lauterbach to bolster its semiconductor design arsenal. Now, if you’ve got your eyes glued to innovation in chip design, like yours truly, then strap in because this merger is more than just a footnote on some dusty tech page. It's a game-changer when it comes...

Continue Reading
Jinko Solar Joins B20 Summit: Energy Forefront Focus

Updated Category News Views 145

Jinko Solar's Invitation to the B20 Summit Never a dull moment in the solar space, especially when Jinko Solar, a big shot in clean energy, jumps into the spotlight at the B20 Summit in the U.S. Awash with high-profile discussions, Jinko's not just chatting—it's the only photovoltaic firm strutting its stuff in D.C. with gutsy calls for energy reform. Key Takeaways from...

Continue Reading
Paulex Bio's Grant Fuels Bold Diabetes Research Push

Updated Category News Views 89

Cracking the Diabetes Code: A New Hope Emerging It ain't every day you hear about a biotech outfit snagging an NIH Fast-Track grant with the potential to upend diabetes treatment, but Paulex Bio's recent score turns heads. Their brainchild, PAL-119, promises to tackle diabetes not by slapping a band-aid on symptoms, but by getting to the rotten core of the disease: the...

Continue Reading
Shukla MD's New Concierge Program Boosts Patient Care

Updated Category News Views 63

Shifting the Healthcare Paradigm Imagine a healthcare world where doctors actually have the time to listen and engage with you beyond just scribbling notes in haste. That's what's brewing over in Westchester, where Dr. Rachana and Dr. Vaishalee Shukla are putting the old-school patient-doctor relationship front and center with their Hybrid Choice concierge program. Run...

Continue Reading
NHTSA, Ad Council Unveil New Anti-Buzzed Driving PSAs

Updated Category News Views 71

Taking Aim at a Deadly Habit Everyone's got that gut feeling when a day-long meeting runs over or you're stuck in traffic — impatience morphed with slow burn menace. Now picture a whole campaign gunning for that vibe but in the hands of the young folks, those from 21 to 34. That's what we're talking about here, with the Ad Council and NHTSA serving up some fresh public...

Continue Reading
Cognizant Boosts Claude AI with 25,000 Pro Workforce

Updated Category News Views 157

Moving AI from Theory to Practice You know, AI isn't about just keeping up with the hype; it's about shoving those algorithms right where they can do the most good—right at the core of business operations. And that’s precisely what Cognizant's cooking up with their fresh-off-the-press Claude Frontier Capability Group. They’ve thrown more than 25,000 pros into the...

Continue Reading
Bandwidth's SI Innovations: A New Dawn or Just Hype?

Updated Category News Views 56

Bandwidth Unleashes Super Intelligence at Reverb Right off the bat, Bandwidth's Reverb showcase was enough to stir up some excitement in the air. The company laid out a feast of technological advancements with their Super Intelligence (SI) innovations that claim to redefine how enterprises communicate. But here's the rub—while these developments sound thrilling, the...

Continue Reading
Parachute Health Urges HME Transformation Through Collaboration

Updated Category News Views 159

The Road to Digital Unity in HME Cranking through the gears of the healthcare industry is no mean feat, but Parachute Health seems ready to throw some fresh oil on the machine. In a landscape riddled with complexities, they're sounding the call for a more unified digital infrastructure in the Home Medical Equipment (HME) sector through their latest white paper. We're...

Continue Reading
What's at Stake: Pearl Diver's Q3 2026 Earnings Call

Updated Category News Views 60

Upcoming Unveiling: Pearl Diver's Latest Financials Heads up, folks. November 16 can't come soon enough for those keeping tabs on Pearl Diver Credit Company Inc. (NYSE: PDCC, PDPA). The bigwigs over there are planning to spill the beans on their third quarter 2026 financial results. They'll kick things off before the market even has its first cup of java on Monday morning...

Continue Reading

Top 5 Most Recently Viewed Articles

Boardwalktech Software to Showcase Innovations at Upcoming Event

Updated Category News Views 161

Boardwalktech Software Demonstrates Commitment to Innovation Boardwalktech Software Corp. (TSXV: BWLK) (OTCQB: BWLKF), recognized as a leader in the Intelligent Information Platform sector, has announced that their CEO and Chairman, Andrew Duncan, is set to present at the highly anticipated Planet MicroCap Showcase. This event, in partnership with MicroCapClub, serves as...

Continue Reading
Sabio Holdings' Creator Television® Earns Top Newcomer Award

Updated Category News Views 136

Sabio Holdings' Creator Television® Triumphs at Industry Awards In an impressive early success, Creator Television®, a project of Sabio Holdings, has clinched the 'Most Significant Newcomer' award at the InteractiveTV Today (ITVT) Awards. This recognition comes as a significant milestone for the company during Creator TV's first six months since launch. An Award for...

Continue Reading
Starbucks Corporation Under Investigation by Kahn Swick & Foti

Updated Category News Views 344

Starbucks Corporation Faces Investigation In recent developments, Kahn Swick & Foti, LLC has started an investigation regarding Starbucks Corporation (NASDAQ: SBUX). Led by former Louisiana Attorney General Charles C. Foti, Jr., this inquiry raises important questions about the company and its executives. Financial Performance Raises Red Flags Starbucks' recent financial...

Continue Reading
Innovative Nitric Oxide Therapy Shows Promise in Cancer Treatment

Updated Category News Views 213

Exploring the Efficacy of LV UNO Therapy in Cancer Treatment Beyond Cancer, Ltd. has introduced groundbreaking preclinical data showcasing the benefits of Low Volume Ultra-High Concentration Nitric Oxide (LV UNO) therapy. This therapy, when combined with immune checkpoint inhibitors, demonstrates significant potential for enhancing patient outcomes in cancer treatments....

Continue Reading
Wabash Partners with Decisiv to Enhance Service Management

Updated Category News Views 305

Wabash and Decisiv Forge a New Partnership Wabash, a leading provider of innovative supply chain solutions, has formed a strategic partnership with Decisiv to enhance service management capabilities within its dealer network. This collaboration aims to streamline service event management and improve uptime for Wabash customers. Decisiv's Impact on Service Management The...

Continue Reading